Patents by Inventor Jeremy C. Jones

Jeremy C. Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral peptides against influenza virus
    Patent number: 9221874
    Abstract: The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: December 29, 2015
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • Peptide adjuvant for influenza vaccination
    Patent number: 9198965
    Abstract: The present disclosure generally relates to peptides having adjuvant properties, vaccines comprising the adjuvant peptides, and their use in prophylaxis or therapy for influenza. More particularly, the invention relates to adjuvant peptides that induce aggregation of influenza virus. The peptides can be included in influenza vaccines to increase the immune response to the vaccine.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: December 1, 2015
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • COMPOSITIONS, METHODS AND USES FOR POXVIRUS ELEMENTS IN VACCINE CONSTRUCTS AGAINST INFLUENZA VIRUS SUBTYPES OR STRAINS
    Publication number: 20150246109
    Abstract: Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions having two or more influenza gene segments. In other embodiments, vaccine compositions are reported of use in a subject.
    Type: Application
    Filed: March 9, 2015
    Publication date: September 3, 2015
    Inventors: Dan T. Stinchcomb, Jorge E. Osorio, Timothy D. Powell, Jeremy C. Jones, Joseph N. Brewoo
  • Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains
    Patent number: 9005632
    Abstract: Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions having two or more influenza gene segments. In other embodiments, vaccine compositions are reported of use in a subject.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: April 14, 2015
    Assignee: Takeda Vaccines, Inc.
    Inventors: Dan T. Stinchcomb, Jorge E. Osorio, Timothy D. Powell, Jeremy C. Jones, Joseph N. Brewoo
  • COMPOSITIONS, METHODS AND USES FOR POXVIRUS ELEMENTS IN VACCINE CONSTRUCTS AGAINST INFLUENZA VIRUS SUBTYPES OR STRAINS
    Publication number: 20130209513
    Abstract: Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions having two or more influenza gene segments. In other embodiments, vaccine compositions are reported of use in a subject.
    Type: Application
    Filed: July 20, 2012
    Publication date: August 15, 2013
    Inventors: Dan T. Stinchcomb, Jorge E. Osorio, Timothy D. Powell, Jeremy C. Jones, Joseph N. Brewoo
  • NOVEL ANTIVIRAL PEPTIDES AGAINST INFLUENZA VIRUS
    Publication number: 20130190228
    Abstract: The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
    Type: Application
    Filed: January 24, 2012
    Publication date: July 25, 2013
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • Antiviral peptides against influenza virus
    Patent number: 8129499
    Abstract: The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: March 6, 2012
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • NOVEL ANTIVIRAL PEPTIDES AGAINST INFLUENZA VIRUS
    Publication number: 20100041604
    Abstract: The present disclosure generally relates to peptides having antiviral properties. More particularly, the invention relates to peptides exhibiting activity against influenza viruses, to pharmaceutical compositions comprising the peptides, and to methods of using the peptides to prevent and/or treat influenza viral infections.
    Type: Application
    Filed: June 15, 2009
    Publication date: February 18, 2010
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones
  • NOVEL PEPTIDE ADJUVANT FOR INFLUENZA VACCINATION
    Publication number: 20100040642
    Abstract: The present disclosure generally relates to peptides having adjuvant properties, vaccines comprising the adjuvant peptides, and their use in prophylaxis or therapy for influenza. More particularly, the invention relates to adjuvant peptides that induce aggregation of influenza virus. The peptides can be included in influenza vaccines to increase the immune response to the vaccine.
    Type: Application
    Filed: June 15, 2009
    Publication date: February 18, 2010
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Stacey L. Schultz-Cherry, Curtis R. Brandt, Jeremy C. Jones